Teva Pharma Industries Ltd ADR TEVA

What the company does

Teva Pharma Industries Ltd ADR is a large-cap company in the Healthcare sector (Drug Manufacturers - Specialty & Generic), with a market value of $47.9B, based in the USA.

It employs about 31,173 people and has been listed since Mar 26, 1990.

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company also focuses on the central nervous system (CNS), respiratory, oncology, and other areas.

Cheap or expensive? relatively cheap

The company is loss-making, so it has no P/E — we compare on price-to-sales instead.

Its price-to-sales (P/S) is 2.8 versus 5.3 for the median of the Healthcare sector in our universe (25 companies) — relatively cheap.

Revenue is shrinking 1% versus the same quarter last year.

The average analyst price target is 45.27, 10% above the current price (their view, not ours).

The stock sits at 96% of its one-year range (0% = the low, 100% = the high).

The risks

• • The company is loss-making.
• • Net debt is 1.7× shareholders' equity — high leverage.

Strengths

• ✅ Generates free cash flow — profit becomes cash in the bank.
• ✅ Most analysts rate it buy (10 vs 0).

What changed this week

Over the past week the stock rose 4.0% (for comparison: S&P 500 +1.2%, sector ETF XLV +2.8%).

It set a new one-year high this week.

No notable news about the company was found in the past week.

What changed since last week

This is the first summary for this stock; from next week this section shows what changed.